Corton Capital Inc. Pacira Bio Sciences, Inc. Transaction History
Corton Capital Inc.
- $168 Million
- Q4 2024
A detailed history of Corton Capital Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 21,575 shares of PCRX stock, worth $537,433. This represents 0.24% of its overall portfolio holdings.
Number of Shares
21,575
Previous 20,361
5.96%
Holding current value
$537,433
Previous $306,000
32.68%
% of portfolio
0.24%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
49.2MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$131 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$81.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$56.2 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$49.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...